P68
Conclusion Apparently, the TMEPAI may be a potential biomarker of malignant transformation risk of the stomach epithelium. The presented study was financially supported by Grants from the Russian Fund for Basic Research (14-04-31500) and Tomsk State University Competitiveness Improvement Program.
Source: European Journal of Cancer Supplements - Category: Cancer & Oncology Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Epithelial Cancer | Gastric (Stomach) Cancer | Gastroenterology | Genetics | Grants | Study